MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…

Continue Reading
2021 Annual Meeting: SDOH Information Exchange Innovation, Referrals, Consent, and Equity

2021 Annual Meeting: SDOH Information Exchange Innovation, Referrals, Consent, and Equity

March 29, 2021This session will explore innovative efforts for SDOH information exchange and interoperable referrals, along with considerations for consent and equity. The session will highlight initiatives from1) CyncHealth, describing the use of HIE to enhance SDOH collaboration in Nebraska2) San Diego Health Connect, noting relevant take-aways from their 2019 LEAP Project for consent and reducing health disparities3) Ohio Health Information Partnership, describing their efforts on SDOH referrals4) Bronx RHIO, discussing community-based health IT efforts to address SDOH, and5) The Gravity Project to provide an update on progress toward SDOH core data for interoperability and standards-based information exchange.Brett Andriesen, ONC, ModeratorElizabeth…

Continue Reading